Future directions in idiopathic pulmonary fibrosis research. An NHLBI workshop report.
暂无分享,去创建一个
H. Collard | K. Anstrom | F. Martinez | I. Noth | G. Raghu | Z. Bar-Joseph | J. Eu | D. Schwartz | S. Violette | N. Kaminski | D. Sheppard | K. Brown | K. Flaherty | R. Wells | T. Oury | L. Ortiz | T. Wynn | R. Deterding | C. Henke | P. Bitterman | C. Marsh | E. White | J. Hagood | D. Tschumperlin | J. Horowitz | V. Thannickal | J. Roman | P. Sime | C. Hogaboam | J. Loyd | G. Cosgrove | W. Bradford | C. Garcia | H. Chapman | B. Moore | A. Tager | T. Blackwell | T. King | M. Blackburn | T. Sisson | Z. Borok | T. Weaver | P. Noble | E. Herzog | W. Lawson | J. Olsson | R. Doyle | T. O'Riordan
[1] Raúl San José Estépar,et al. MUC5B Promoter Polymorphism and Interstitial Lung Abnormalities , 2013 .
[2] T. Oury,et al. Animal models of fibrotic lung disease. , 2013, American journal of respiratory cell and molecular biology.
[3] T. Blackwell,et al. Endoplasmic reticulum stress as a pro-fibrotic stimulus. , 2013, Biochimica et biophysica acta.
[4] A. Tager,et al. Fibrosis of two: Epithelial cell-fibroblast interactions in pulmonary fibrosis. , 2013, Biochimica et biophysica acta.
[5] I. Noth,et al. Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosis. , 2013, JAMA.
[6] Naftali Kaminski,et al. Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study. , 2013, The Lancet. Respiratory medicine.
[7] A. Montgomery,et al. Idiopathic pulmonary fibrosis: clinically meaningful primary endpoints in phase 3 clinical trials. , 2013, American journal of respiratory and critical care medicine.
[8] Brent S. Pedersen,et al. Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis , 2013, Nature Genetics.
[9] Carla M. T. Bauer,et al. Bleomycin Induces Molecular Changes Directly Relevant to Idiopathic Pulmonary Fibrosis: A Model for “Active” Disease , 2013, PloS one.
[10] F. Sciurba,et al. Patients with idiopathic pulmonary fibrosis with antibodies to heat shock protein 70 have poor prognoses. , 2013, American journal of respiratory and critical care medicine.
[11] J. Duffield,et al. Host responses in tissue repair and fibrosis. , 2013, Annual review of pathology.
[12] F. Martinez,et al. Periostin promotes fibrosis and predicts progression in patients with idiopathic pulmonary fibrosis. , 2012, American journal of physiology. Lung cellular and molecular physiology.
[13] L. T. Krug,et al. Role of endoplasmic reticulum stress in age-related susceptibility to lung fibrosis. , 2012, American journal of respiratory cell and molecular biology.
[14] N. Kaminski,et al. Peripheral blood proteins predict mortality in idiopathic pulmonary fibrosis. , 2012, American journal of respiratory and critical care medicine.
[15] T. Barker,et al. Matrix stiffness-induced myofibroblast differentiation is mediated by intrinsic mechanotransduction. , 2012, American journal of respiratory cell and molecular biology.
[16] D. Kotton,et al. Next-generation regeneration: the hope and hype of lung stem cell research. , 2012, American journal of respiratory and critical care medicine.
[17] C. Garcia,et al. Mutant surfactant A2 proteins associated with familial pulmonary fibrosis and lung cancer induce TGF-β1 secretion , 2012, Proceedings of the National Academy of Sciences.
[18] Ivana V. Yang,et al. The next generation of complex lung genetic studies. , 2012, American journal of respiratory and critical care medicine.
[19] M. Kahn,et al. Profibrotic role of miR-154 in pulmonary fibrosis. , 2012, American journal of respiratory cell and molecular biology.
[20] Oliver Eickelberg,et al. The impact of TGF-β on lung fibrosis: from targeting to biomarkers. , 2012, Proceedings of the American Thoracic Society.
[21] Kevin Weiss,et al. Acellular normal and fibrotic human lung matrices as a culture system for in vitro investigation. , 2012, American journal of respiratory and critical care medicine.
[22] K. Brown,et al. Clinical trials and tribulations--lessons from pulmonary fibrosis. , 2012, QJM : monthly journal of the Association of Physicians.
[23] R. D. du Bois,et al. Idiopathic pulmonary fibrosis: lung function is a clinically meaningful endpoint for phase III trials. , 2012, American journal of respiratory and critical care medicine.
[24] A. Wells. Forced vital capacity as a primary end point in idiopathic pulmonary fibrosis treatment trials: making a silk purse from a sow's ear , 2012, Thorax.
[25] N. Kaminski,et al. Biomarkers in idiopathic pulmonary fibrosis , 2012, Current opinion in pulmonary medicine.
[26] D. Fairclough,et al. Patient-reported outcomes in idiopathic pulmonary fibrosis research. , 2012, Chest.
[27] Hong Peng,et al. Fibrocytes: emerging effector cells in chronic inflammation. , 2012, Current opinion in pharmacology.
[28] W. H. Goldmann,et al. Mechanotransduction and focal adhesions , 2012, Cell biology international.
[29] T. Moore,et al. Pulmonary fibrosis induced by γ-herpesvirus in aged mice is associated with increased fibroblast responsiveness to transforming growth factor-β. , 2012, The journals of gerontology. Series A, Biological sciences and medical sciences.
[30] T. Wynn,et al. Mechanisms of fibrosis: therapeutic translation for fibrotic disease , 2012, Nature Medicine.
[31] Ivana V. Yang,et al. The Peripheral Blood Transcriptome Identifies the Presence and Extent of Disease in Idiopathic Pulmonary Fibrosis , 2012, PloS one.
[32] Joyce S Lee,et al. A Multidimensional Index and Staging System for Idiopathic Pulmonary Fibrosis , 2012, Annals of Internal Medicine.
[33] Z. Yakhini,et al. Global Methylation Patterns in Idiopathic Pulmonary Fibrosis , 2012, PloS one.
[34] Jenna L Balestrini,et al. The mechanical memory of lung myofibroblasts. , 2012, Integrative biology : quantitative biosciences from nano to macro.
[35] D. Boettiger,et al. Fibronectin extra domain-A promotes hepatic stellate cell motility but not differentiation into myofibroblasts. , 2012, Gastroenterology.
[36] Imre Noth,et al. Peripheral blood biomarkers in idiopathic pulmonary fibrosis. , 2012, Translational research : the journal of laboratory and clinical medicine.
[37] J. L. Newman,et al. Telomerase deficiency does not alter bleomycin-induced fibrosis in mice , 2012, Experimental lung research.
[38] Michael J. Cronce,et al. Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesenchymal transition , 2011, Proceedings of the National Academy of Sciences.
[39] T. Wynn,et al. Protective and pathogenic functions of macrophage subsets , 2011, Nature Reviews Immunology.
[40] B. Hogan,et al. Epithelial progenitor cells in lung development, maintenance, repair, and disease. , 2011, Annual review of cell and developmental biology.
[41] S. Forbes,et al. Ly6Chi monocytes direct alternatively activated profibrotic macrophage regulation of lung fibrosis. , 2011, American journal of respiratory and critical care medicine.
[42] Thomas A. Wynn,et al. Integrating mechanisms of pulmonary fibrosis , 2011, The Journal of experimental medicine.
[43] J. Hagood,et al. Epigenetic regulation of thy-1 by histone deacetylase inhibitor in rat lung fibroblasts. , 2011, American journal of respiratory cell and molecular biology.
[44] F. Martinez,et al. A Micro RNA Processing Defect in Rapidly Progressing Idiopathic Pulmonary Fibrosis , 2011, PloS one.
[45] E. Morrisey,et al. Endoplasmic reticulum stress enhances fibrotic remodeling in the lungs , 2011, Proceedings of the National Academy of Sciences.
[46] E. Morrisey,et al. The three R's of lung health and disease: repair, remodeling, and regeneration. , 2011, The Journal of clinical investigation.
[47] R. Bucala,et al. Local apoptosis promotes collagen production by monocyte-derived cells in transforming growth factor β1-induced lung fibrosis , 2011, Fibrogenesis & tissue repair.
[48] Ivana V. Yang,et al. A common MUC5B promoter polymorphism and pulmonary fibrosis. , 2011, The New England journal of medicine.
[49] Takeshi Johkoh,et al. American Thoracic Society Documents An Official ATS / ERS / JRS / ALAT Statement : Idiopathic Pulmonary Fibrosis : Evidence-based Guidelines for Diagnosis and Management , 2011 .
[50] H. Collard,et al. Clinical course and prediction of survival in idiopathic pulmonary fibrosis. , 2011, American journal of respiratory and critical care medicine.
[51] S. Kato,et al. Periostin, a matrix protein, is a novel biomarker for idiopathic interstitial pneumonias , 2010, European Respiratory Journal.
[52] F. Martinez,et al. TLR9 Differentiates Rapidly from Slowly Progressing Forms of Idiopathic Pulmonary Fibrosis , 2010, Science Translational Medicine.
[53] A. Desmoulière,et al. The Myofibroblast: one function, multiple origins , 2010 .
[54] A. Kho,et al. Feedback amplification of fibrosis through matrix stiffening and COX-2 suppression , 2010, The Journal of cell biology.
[55] Luke Barron,et al. Macrophages: Master Regulators of Inflammation and Fibrosis , 2010, Seminars in liver disease.
[56] D. Ingber,et al. Reconstituting Organ-Level Lung Functions on a Chip , 2010, Science.
[57] Christine M. Micheel,et al. Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease , 2010 .
[58] G. Raghu,et al. Ascertainment of individual risk of mortality for patients with idiopathic pulmonary fibrosis. , 2010, American journal of respiratory and critical care medicine.
[59] T. Wynn,et al. Bleomycin and IL-1β–mediated pulmonary fibrosis is IL-17A dependent , 2010, The Journal of experimental medicine.
[60] Michael S. Kramer,et al. Serum Amyloid P Therapeutically Attenuates Murine Bleomycin-Induced Pulmonary Fibrosis via Its Effects on Macrophages , 2010, PloS one.
[61] N. Kaminski,et al. CD28 Down-Regulation on Circulating CD4 T-Cells Is Associated with Poor Prognoses of Patients with Idiopathic Pulmonary Fibrosis , 2010, PloS one.
[62] Z. Werb,et al. Mfge8 diminishes the severity of tissue fibrosis in mice by binding and targeting collagen for uptake by macrophages. , 2009, Journal of Clinical Investigation.
[63] M. Burdick,et al. Fibrocyte CXCR4 regulation as a therapeutic target in pulmonary fibrosis. , 2009, The international journal of biochemistry & cell biology.
[64] Jin Woo Song,et al. Gene expression profiles of acute exacerbations of idiopathic pulmonary fibrosis. , 2009, American journal of respiratory and critical care medicine.
[65] M. Olschewski,et al. Serum CC-chemokine ligand 18 concentration predicts outcome in idiopathic pulmonary fibrosis. , 2009, American journal of respiratory and critical care medicine.
[66] P. O'Byrne,et al. Circulating fibrocytes are an indicator of poor prognosis in idiopathic pulmonary fibrosis. , 2009, American journal of respiratory and critical care medicine.
[67] Guoying Yu,et al. Oxidative Stress Alters Syndecan-1 Distribution in Lungs with Pulmonary Fibrosis* , 2009, Journal of Biological Chemistry.
[68] N. Grishin,et al. Genetic defects in surfactant protein A2 are associated with pulmonary fibrosis and lung cancer. , 2009, American journal of human genetics.
[69] Raghu Kalluri,et al. Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition. , 2008, Journal of the American Society of Nephrology : JASN.
[70] R. Kalluri,et al. Fibroblasts emerge via epithelial-mesenchymal transition in chronic kidney fibrosis. , 2008, Frontiers in bioscience : a journal and virtual library.
[71] T. Oury,et al. Extracellular Superoxide Dismutase Inhibits Inflammation by Preventing Oxidative Fragmentation of Hyaluronan* , 2008, Journal of Biological Chemistry.
[72] N. Kaminski,et al. A role for the receptor for advanced glycation end products in idiopathic pulmonary fibrosis. , 2008, The American journal of pathology.
[73] R L Ehman,et al. MR elastography of the lung with hyperpolarized 3He , 2008, Magnetic resonance in medicine.
[74] B. Hinz,et al. Myofibroblast contraction activates latent TGF-β1 from the extracellular matrix , 2007, The Journal of cell biology.
[75] P. Janmey,et al. Increased stiffness of the rat liver precedes matrix deposition: implications for fibrosis. , 2007, American journal of physiology. Gastrointestinal and liver physiology.
[76] J. Dranoff,et al. Transforming growth factor‐β and substrate stiffness regulate portal fibroblast activation in culture , 2007, Hepatology.
[77] R. Flavell,et al. IL-13Ralpha2 and IL-10 coordinately suppress airway inflammation, airway-hyperreactivity, and fibrosis in mice. , 2007, The Journal of clinical investigation.
[78] R. Chambers,et al. Molecular targets in pulmonary fibrosis: the myofibroblast in focus. , 2007, Chest.
[79] N. Kaminski,et al. Accelerated Variant of Idiopathic Pulmonary Fibrosis: Clinical Behavior and Gene Expression Pattern , 2007, PloS one.
[80] Chao Xing,et al. Adult-onset pulmonary fibrosis caused by mutations in telomerase , 2007, Proceedings of the National Academy of Sciences.
[81] F. Martinez,et al. Therapeutic targeting of CC ligand 21 or CC chemokine receptor 7 abrogates pulmonary fibrosis induced by the adoptive transfer of human pulmonary fibroblasts to immunodeficient mice. , 2007, The American journal of pathology.
[82] P. Lansdorp,et al. Telomerase mutations in families with idiopathic pulmonary fibrosis. , 2007, The New England journal of medicine.
[83] J. Iredale,et al. Liver fibrosis: cellular mechanisms of progression and resolution. , 2007, Clinical science.
[84] D. Sheppard,et al. Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix , 2006, Proceedings of the National Academy of Sciences.
[85] M. Selman,et al. Role of epithelial cells in idiopathic pulmonary fibrosis: from innocent targets to serial killers. , 2006, Proceedings of the American Thoracic Society.
[86] L. Murray,et al. The role of CCL12 in the recruitment of fibrocytes and lung fibrosis. , 2006, American journal of respiratory cell and molecular biology.
[87] K. G. Lewis,et al. Increased and prolonged pulmonary fibrosis in surfactant protein C-deficient mice following intratracheal bleomycin. , 2005, The American journal of pathology.
[88] R. Wells. The role of matrix stiffness in hepatic stellate cell activation and liver fibrosis. , 2005, Journal of clinical gastroenterology.
[89] V. Ambrosini,et al. Genetic mutations in surfactant protein C are a rare cause of sporadic cases of IPF , 2004, Thorax.
[90] J. Milbrandt,et al. Early Growth Response Gene 1–mediated Apoptosis Is Essential for Transforming Growth Factor β1–induced Pulmonary Fibrosis , 2004, The Journal of experimental medicine.
[91] M. Burdick,et al. Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. , 2004, The Journal of clinical investigation.
[92] T. Wynn. Fibrotic disease and the TH1/TH2 paradigm , 2004, Nature Reviews Immunology.
[93] Roger D. Kamm,et al. Mechanotransduction through growth-factor shedding into the extracellular space , 2004, Nature.
[94] Hideo Yokota,et al. Localized compliance of small airways in excised rat lungs using microfocal X-ray computed tomography. , 2004, Journal of applied physiology.
[95] L. Parry,et al. Relaxin deficiency in mice is associated with an age‐related progression of pulmonary fibrosis , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[96] D. A. Schwartz,et al. Future research directions in idiopathic pulmonary fibrosis: summary of a National Heart, Lung, and Blood Institute working group. , 2002, American journal of respiratory and critical care medicine.
[97] Jonathan Haines,et al. Heterozygosity for a surfactant protein C gene mutation associated with usual interstitial pneumonitis and cellular nonspecific interstitial pneumonitis in one kindred. , 2002, American journal of respiratory and critical care medicine.
[98] Naftali Kaminski,et al. Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[99] E. Puré,et al. Resolution of Lung Inflammation by CD44 , 2002, Science.
[100] A. Pardo,et al. Idiopathic Pulmonary Fibrosis: Prevailing and Evolving Hypotheses about Its Pathogenesis and Implications for Therapy , 2001, Annals of Internal Medicine.
[101] B. Antus,et al. Influence of alternatively and classically activated macrophages on fibrogenic activities of human fibroblasts. , 2000, Cellular immunology.
[102] S. Heffelfinger,et al. Overexpression of transforming growth factor-alpha and epidermal growth factor-receptor in idiopathic pulmonary fibrosis. , 1999, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.
[103] A. Geinoz,et al. The Fibronectin Domain ED-A Is Crucial for Myofibroblastic Phenotype Induction by Transforming Growth Factor-β1 , 1998, The Journal of cell biology.
[104] J. Iredale,et al. Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. , 1998, The Journal of clinical investigation.
[105] K. Csaky,et al. Adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung. , 1997, The Journal of clinical investigation.
[106] R. Bucala,et al. Circulating Fibrocytes Define a New Leukocyte Subpopulation That Mediates Tissue Repair , 1994, Molecular medicine.
[107] Alexandra Naba,et al. Overview of the matrisome--an inventory of extracellular matrix constituents and functions. , 2012, Cold Spring Harbor perspectives in biology.
[108] C. Spradley. Gastroesophageal Reflux Therapy Is Associated with Longer Survival in Patients with Idiopathic Pulmonary Fibrosis , 2012 .
[109] Michael S. Kramer,et al. TGF-beta driven lung fibrosis is macrophage dependent and blocked by Serum amyloid P. , 2011, The international journal of biochemistry & cell biology.
[110] K. Pandit,et al. MicroRNAs in idiopathic pulmonary fibrosis. , 2011, Translational research : the journal of laboratory and clinical medicine.
[111] A. McMahon,et al. Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. , 2010, The American journal of pathology.
[112] Ivana V. Yang,et al. Gene expression profiling of familial and sporadic interstitial pneumonia. , 2007, American journal of respiratory and critical care medicine.
[113] T. Wynn. Fibrotic disease and the T(H)1/T(H)2 paradigm. , 2004, Nature reviews. Immunology.
[114] M. Selman,et al. AMERICAN THORACIC SOCIETY; EUROPEAN RESPIRATORY SOCIETY; AMERICAN COLLEGE OF CHEST PHYSICIANS. IDIOPATHIC PULMONARY FIBROSIS: PREVAILING AND EVOLVING HYPOTHESES ABOUT ITS PATHOGENESIS AND IMPLICATIONS FOR THERAPY , 2001 .
[115] David A. Lynch,et al. Idiopathic pulmonary fibrosis: Diagnosis and treatment: International Consensus Statement , 2000 .